<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37606391</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2035-8385</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>25</Day></PubDate></JournalIssue><Title>Neurology international</Title><ISOAbbreviation>Neurol Int</ISOAbbreviation></Journal><ArticleTitle>Persistent 18F-FDG Brain PET Fronto-Temporal Hypometabolism and Cognitive Symptoms Two Years after SARS-CoV-2 Infection: A Case Report.</ArticleTitle><Pagination><StartPage>908</StartPage><EndPage>916</EndPage><MedlinePgn>908-916</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/neurolint15030058</ELocationID><Abstract><AbstractText>At least 10% of patients experience persistent symptoms after SARS-CoV-2 infection, a condition referred to as post-acute COVID-19, post-acute sequelae of SARS-CoV-2 infection (PASC), long COVID, long-haul COVID, long-term effects of COVID, post-COVID-19 and chronic COVID. In this report, we describe a case of persistent cognitive deficits developed after SARS-CoV-2 infection in a 40-year-old woman with a family history of early-onset Alzheimer's disease (EOAD) since her father was diagnosed with EOAD at the age of 50. We describe the clinical picture and workup, with special emphasis on the alterations of brain glucose metabolism evidenced by 18-fluoro-deoxy-glucose positron emission tomography (FDG-PET), which could be considered a useful marker of the presence and persistence of cognitive deficits.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neuropsychology and Speech Therapy Unit, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prodi</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morese</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4939-6539</Identifier><AffiliationInfo><Affiliation>Faculty of Biomedical Sciences, Universit&#xe0; della Svizzera Italiana, 6900 Lugano, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Communication, Culture and Society, Universit&#xe0; della Svizzera Italiana, 6900 Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paone</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Faculty of Biomedical Sciences, Universit&#xe0; della Svizzera Italiana, 6900 Lugano, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruberto</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacco</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9494-7742</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Neuropsychology and Speech Therapy Unit, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Neurol Int</MedlineTA><NlmUniqueID>101551564</NlmUniqueID><ISSNLinking>2035-8385</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">FDG-PET</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>13</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37606391</ArticleId><ArticleId IdType="pmc">PMC10443341</ArticleId><ArticleId IdType="doi">10.3390/neurolint15030058</ArticleId><ArticleId IdType="pii">neurolint15030058</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou M.-I., Palaiodimou L., Bakola E., Smyrnis N., Papadopoulou M., Paraskevas G.P., Rizos E., Boutati E., Grigoriadis N., Krogias C., et al. Neurological manifestations of long-COVID syndrome: A narrative review. Ther. Adv. Chronic Dis. 2022;13:204062232210768. doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Alcoba G., Perone S.A., Courvoisier D., Chappuis F., Guessous I. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Ann. Intern. Med. 2021;174:723&#x2013;725. doi: 10.7326/M20-5926.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5926</ArticleId><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators. Hanson S.W., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., et al. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechner-Scott J., Levy M., Hawkes C., Yeh A., Giovannoni G. Long COVID or post COVID-19 syndrome. Mult. Scler. Relat. Disord. 2021;55:103268. doi: 10.1016/j.msard.2021.103268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.103268</ArticleId><ArticleId IdType="pmc">PMC8447548</ArticleId><ArticleId IdType="pubmed">34601388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain, Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L., Palmer K., Calandri I., Guekht A., Beghi E., Carroll W., Frontera J., Garc&#xed;a-Azor&#xed;n D., Westenberg E., Winkler A.S., et al. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimer&#x2019;s Dement. 2022;18:1047&#x2013;1066. doi: 10.1002/alz.12644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12644</ArticleId><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T., Workman C.D., Ponto L.L.B. 18F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations. Viruses. 2021;13:2283. doi: 10.3390/v13112283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112283</ArticleId><ArticleId IdType="pmc">PMC8625263</ArticleId><ArticleId IdType="pubmed">34835088</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-J&#xfa;nior J.W., de Souza A.C., Borges J.W., Oliveira D.N., Siqueira-Neto J.I., Sobreira-Neto M.A., Braga-Neto P. COVID-19 associated cognitive impairment: A systematic review. Cortex. 2022;152:77&#x2013;97. doi: 10.1016/j.cortex.2022.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2022.04.006</ArticleId><ArticleId IdType="pmc">PMC9014565</ArticleId><ArticleId IdType="pubmed">35537236</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C., Bentivegna E., Cho S.-J., Harriott A.M., Garc&#xed;a-Azor&#xed;n D., Labastida-Ramirez A., Ornello R., Raffaelli B., Beltr&#xe1;n E.R., Ruscheweyh R., et al. Long COVID headache. J. Headache Pain. 2022;23:93. doi: 10.1186/s10194-022-01450-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine Z.S., Phillips N.A., B&#xe9;dirian V., Charbonneau S., Whitehead V., Collin I., Cummings J.L., Chertkow H. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. J. Am. Geriatr. Soc. 2005;53:695&#x2013;699. doi: 10.1111/j.1532-5415.2005.53221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C. The Chalder Fatigue Scale (CFQ 11) Occup. Med. 2014;65:86. doi: 10.1093/occmed/kqu168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqu168</ArticleId><ArticleId IdType="pubmed">25559796</ArticleId></ArticleIdList></Reference><Reference><Citation>Brickenkamp R., Zilmer E. The d2 Test of Attention. Hogrefe and Huber Publishers; Seattle, WA, USA: 1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/t03299-000</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey A. Clinical Tests in Psychology. Presses Universitaires de France; Paris, France: 1964. L &#x2018;examen clinique en psychologie.</Citation></Reference><Reference><Citation>Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 1983;67:361&#x2013;370. doi: 10.1111/j.1600-0447.1983.tb09716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack C.R., Bennett D.A., Blennow K., Carrillo M.C., Dunn B., Haeberlein S.B., Holtzman D.M., Jagust W., Jessen F., Karlawish J., et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2018;14:535&#x2013;562. doi: 10.1016/j.jalz.2018.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.018</ArticleId><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S., Stomrud E., Palmqvist S., Zetterberg H., van Westen D., Jeromin A., Song L., Hanlon D., Hehir C.A.T., Baker D., et al. Plasma &#x3b2;-amyloid in Alzheimer&#x2019;s disease and vascular disease. Sci. Rep. 2016;6:26801. doi: 10.1038/srep26801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep26801</ArticleId><ArticleId IdType="pmc">PMC4886210</ArticleId><ArticleId IdType="pubmed">27241045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewczuk P., Mroczko B., Fagan A., Kornhuber J. Biomarkers of Alzheimer&#x2019;s disease and mild cognitive impairment: A current perspective. Adv. Med. Sci. 2015;60:76&#x2013;82. doi: 10.1016/j.advms.2014.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.advms.2014.11.002</ArticleId><ArticleId IdType="pubmed">25579841</ArticleId></ArticleIdList></Reference><Reference><Citation>Graus F., Vogrig A., Mu&#xf1;iz-Castrillo S., Antoine J.-C.G., Desestret V., Dubey D., Giometto B., Irani S.R., Joubert B., Leypoldt F., et al. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurol. Neuroimmunol. Neuroinflammation. 2021;8:e1014. doi: 10.1212/NXI.0000000000001014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001014</ArticleId><ArticleId IdType="pmc">PMC8237398</ArticleId><ArticleId IdType="pubmed">34006622</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirkis D.W., Bonham L.W., Johnson T.P., La Joie R., Yokoyama J.S. Dissecting the clinical heterogeneity of early-onset Alzheimer&#x2019;s disease. Mol. Psychiatry. 2022;27:2674&#x2013;2688. doi: 10.1038/s41380-022-01531-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01531-9</ArticleId><ArticleId IdType="pmc">PMC9156414</ArticleId><ArticleId IdType="pubmed">35393555</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman D.S., Amieva H., Petersen R.C., Ch&#xe9;telat G., Holtzman D.M., Hyman B.T., Nixon R.A., Jones D.T. Alzheimer disease. Nat. Rev. Dis. Prim. 2021;7:115&#x2013;140. doi: 10.1038/s41572-021-00269-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00269-y</ArticleId><ArticleId IdType="pmc">PMC8574196</ArticleId><ArticleId IdType="pubmed">33986301</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., et al. The diagnosis of dementia due to Alzheimer&#x2019;s disease: Recommendations from the National Institute on Aging-Alzheimer&#x2019;s association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers Dement. J. Alzheimers Assoc. 2011;7:263&#x2013;269. doi: 10.1016/j.jalz.2011.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.03.005</ArticleId><ArticleId IdType="pmc">PMC3312024</ArticleId><ArticleId IdType="pubmed">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockett D.J., Hadjistavropoulos T., Hurwitz T. Primacy and recency effects in the assessment of memory using the Rey Auditory Verbal Learning Test. Arch. Clin. Neuropsychol. 1992;7:97&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">14589682</ArticleId></ArticleIdList></Reference><Reference><Citation>Waugh N.C., Norman D.A. Primary memory. Psychol. Rev. 1965;72:89&#x2013;104. doi: 10.1037/h0021797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/h0021797</ArticleId><ArticleId IdType="pubmed">14282677</ArticleId></ArticleIdList></Reference><Reference><Citation>Consonni M., Rossi S., Cerami C., Marcone A., Iannaccone S., Cappa S.F., Perani D. Executive dysfunction affects word list recall performance: Evidence from amyotrophic lateral sclerosis and other neurodegenerative diseases. J. Neuropsychol. 2015;11:74&#x2013;90. doi: 10.1111/jnp.12072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnp.12072</ArticleId><ArticleId IdType="pubmed">25952058</ArticleId></ArticleIdList></Reference><Reference><Citation>Cian V., De Laurenzis A., Siri C., Gusmeroli A., Canesi M. Cognitive and Neuropsychiatric Features of COVID-19 Patients After Hospital Dismission: An Italian Sample. Front. Psychol. 2022;13:908363. doi: 10.3389/fpsyg.2022.908363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2022.908363</ArticleId><ArticleId IdType="pmc">PMC9173000</ArticleId><ArticleId IdType="pubmed">35686079</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J. Long-COVID: Cognitive deficits (brain fog) and brain lesions in non&#x2013;hospitalized patients. Presse M&#xe9;dicale. 2022;51:104090. doi: 10.1016/j.lpm.2021.104090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2021.104090</ArticleId><ArticleId IdType="pmc">PMC8552626</ArticleId><ArticleId IdType="pubmed">34718113</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J., Msika E.-F., Queneau M., Farid K., Paquet C. Long COVID: Cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J. Neurol. 2021;269:44&#x2013;46. doi: 10.1007/s00415-021-10655-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu A.T., Absar N.M. Long-term Neuropsychiatric Complications and 18F-FDG-PET Hypometabolism in the Brain From Prolonged Infection of COVID-19. Alzheimer Dis. Assoc. Disord. 2021;36:173&#x2013;175. doi: 10.1097/WAD.0000000000000485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000485</ArticleId><ArticleId IdType="pmc">PMC9132237</ArticleId><ArticleId IdType="pubmed">34966022</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., Guis S., Barthelemy F., Habert P., Ceccaldi M., et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Morand A., Campion J.-Y., Lepine A., Bosdure E., Luciani L., Cammilleri S., Chabrol B., Guedj E. Similar patterns of [18F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: A paediatric case series. Eur. J. Nucl. Med. 2021;49:913&#x2013;920. doi: 10.1007/s00259-021-05528-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05528-4</ArticleId><ArticleId IdType="pmc">PMC8376118</ArticleId><ArticleId IdType="pubmed">34414470</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo S., Di Lorenzo F., Scarioni M., Frederiksen K.S., Nobili F. Is the Frontal Lobe the Primary Target of SARS-CoV-2? J. Alzheimer&#x2019;s Dis. 2021;81:75&#x2013;81. doi: 10.3233/JAD-210008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210008</ArticleId><ArticleId IdType="pubmed">33720900</ArticleId></ArticleIdList></Reference><Reference><Citation>Herholz K., Salmon E., Perani D., Baron J.-C., Holthoff V., Fr&#xf6;lich L., Sch&#xf6;nknecht P., Ito K., Mielke R., Kalbe E. Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET. Neuroimage. 2002;17:302&#x2013;316. doi: 10.1006/nimg.2002.1208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nimg.2002.1208</ArticleId><ArticleId IdType="pubmed">12482085</ArticleId></ArticleIdList></Reference><Reference><Citation>Dressing A., Bormann T., Blazhenets G., Schroeter N., Walter L.I., Thurow J., August D., Hilger H., Stete K., Gerstacker K., et al. Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome. J. Nucl. Med. 2021;63:1058&#x2013;1063. doi: 10.2967/jnumed.121.262677.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262677</ArticleId><ArticleId IdType="pmc">PMC9258569</ArticleId><ArticleId IdType="pubmed">34649946</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazhenets G., Schroeter N., Bormann T., Thurow J., Wagner D., Frings L., Weiller C., Meyer P.T., Dressing A., A Hosp J. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J. Nucl. Med. 2021;62:910&#x2013;915. doi: 10.2967/jnumed.121.262128.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262128</ArticleId><ArticleId IdType="pmc">PMC8882885</ArticleId><ArticleId IdType="pubmed">33789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R., Cuffaro L., Capozza A., Rosci C., Maiorana N., Groppo E., Reitano M.R., Poletti B., Ticozzi N., Tagliabue L., et al. Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19. J. Neurol. 2023;270:1823&#x2013;1834. doi: 10.1007/s00415-022-11543-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11543-8</ArticleId><ArticleId IdType="pmc">PMC9873215</ArticleId><ArticleId IdType="pubmed">36692636</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>